🇺🇸 FDA
Pipeline program

Cabergoline 1 MG

71540

Phase 2 small_molecule completed

Quick answer

Cabergoline 1 MG for Lactation Suppressed is a Phase 2 program (small_molecule) at Monte Rosa Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Monte Rosa Therapeutics
Indication
Lactation Suppressed
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials